...Avenue’s IV tramadolAvenue Therapeutics Inc. (NASDAQ:ATXI) received a complete response letter from FDA for IV tramadol...

...a January Frontiers in Pharmacology study . Desmetramadol is the active metabolite of the opioid tramadol...

...for a drug that’s clearly less abused even if it isn’t as effective, and highlighted tramadol...

...meetings are scheduled for three other pain therapies this week: a fixed dose combination of tramadol...

...data 3Q19 Revogenex Inc. / Fortress Biotech Inc. (NASDAQ:FBIO) / Avenue Therapeutics Inc. (NASDAQ:ATXI) IV tramadol...

...Bypassing the metabolic conversion required for Schedule IV opiate tramadol to achieve analgesia, Syntrix has positioned...
...to achieve analgesia, Syntrix has positioned desmetramadol as a safer and more effective pain therapy. Tramadol...
...as tramadol without the variability. According to Syntrix President, CEO and Founder John Zebala, both tramadol...

...enrolled 3,021 patients who had inadequate pain relief from or intolerance to acetaminophen and either tramadol...

...BLA 2Q19 Revogenex Inc. / Fortress Biotech Inc. (NASDAQ:FBIO) / Avenue Therapeutics Inc. (NASDAQ:ATXI) IV tramadol...

...date 6/30/18 Avenue Therapeutics Inc. (NASDAQ:ATXI) / Fortress Biotech Inc. (NASDAQ:FBIO) / Revogenex Inc. IV tramadol...

...Early 2018 Avenue Therapeutics Inc. (NASDAQ:ATXI) / Fortress Biotech Inc. (NASDAQ:FBIO) / Revogenex Inc. IV tramadol...